Sugi Predict

Sugi Predict / Targets / CFAP20

CFAP20

Cilia- and flagella-associated protein 20 · Q9Y6A4 · CFAP20 on Sugi Atlas →

0 patent compounds predicted against CFAP20, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CFAP20 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD PHASE1COMPLETED
Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance PHASE1COMPLETED
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype EARLY_PHASE1COMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Genotype/Phenotype Correlation With Focus on Lung Function in Primary Ciliary Dyskinesia (PCD) nanUNKNOWN
Early Detection and Characterization of Primary Ciliary Dyskinesia nanUNKNOWN
Mapping Disease Pathways for Biliary Atresia nanRECRUITING
WGS of Korean Idiopathic Bronchiectasis nanUNKNOWN
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials nanACTIVE_NOT_RECRUITING
Natural History of Asphyxiating Thoracic Dystrophy (DTJ) nanCOMPLETED
Primary Ciliary Dyskinesia in Adult Bronchiectasis nanNOT_YET_RECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Respiratory Registry for Lung Health: a Prospective, Observational Study on Adult Patients With Asthma or COPD nanUNKNOWN
FA Clinical Outcome Measures nanACTIVE_NOT_RECRUITING
CABP2 Patient Registry and Natural History Study nanRECRUITING
Nasal Nitric Oxide Across Mutations in Primary Ciliary Dyskinesia nanUNKNOWN
Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia nanRECRUITING
Genomic Study of Congenital Malformation nanUNKNOWN
Genetic Diagnosis in Congenital Cataracts nanCOMPLETED
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI) nanRECRUITING
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CFAP20 binder may also engage these)

ProteinNameSimilarity
Q6B857 — 1.000 Q6B857 →
Q6GL74 — 1.000 Q6GL74 →
Q5ZHP3 — 1.000 Q5ZHP3 →
Q8BTU1 — 1.000 Q8BTU1 →
Q6PBJ2 — 1.000 Q6PBJ2 →
Q6GPY6 — 0.998 Q6GPY6 →
Q9VKV8 — 0.997 Q9VKV8 →
A0CDD4 — 0.990 A0CDD4 →
Q499T7 — 0.971 Q499T7 →
A8IU92 — 0.959 A8IU92 →
GNPDA1 Glucosamine-6-phosphate deaminase 1 0.924 landscape →
P48597 — 0.924 P48597 →
A4FV08 — 0.924 A4FV08 →
Q3SYW1 — 0.923 Q3SYW1 →
Q9DFS6 — 0.923 Q9DFS6 →
Q5R8T8 — 0.922 Q5R8T8 →
Q503E1 — 0.922 Q503E1 →
KCNT2 Potassium channel subfamily T member 2 0.922 landscape →
Q8TDQ7 — 0.922 Q8TDQ7 →
Q17QL1 — 0.922 Q17QL1 →
Q8LPJ4 — 0.920 Q8LPJ4 →
Q6PA43 — 0.920 Q6PA43 →
P48454 — 0.919 P48454 →
Q9CZX0 — 0.919 Q9CZX0 →
Q9CRC9 — 0.919 Q9CRC9 →
PPP3CA Protein phosphatase 3 catalytic subunit alpha 0.919 landscape →
Q2YDM2 — 0.919 Q2YDM2 →
Q5ZJL4 — 0.918 Q5ZJL4 →
P63329 — 0.918 P63329 →
P20651 — 0.918 P20651 →